2021
DOI: 10.1111/trf.16326
|View full text |Cite
|
Sign up to set email alerts
|

Two roads diverged: Emerging lessons from IVIG about hemolysis

Abstract: http://onlinelibrary.wiley.com/doi/10.1111/trf.16232/full

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

1
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 14 publications
1
1
0
Order By: Relevance
“… 25 Acute haemolysis has been reported during IVIg treatment; 26 , 27 and the patients had serum antibodies against blood-group antigens; and some patients, mainly those with a non-O blood group, had haemolytic reactions during IVIg infusion. 24 The current patient’s blood was type A, consistent with these findings.…”
Section: Discussionsupporting
confidence: 83%
See 1 more Smart Citation
“… 25 Acute haemolysis has been reported during IVIg treatment; 26 , 27 and the patients had serum antibodies against blood-group antigens; and some patients, mainly those with a non-O blood group, had haemolytic reactions during IVIg infusion. 24 The current patient’s blood was type A, consistent with these findings.…”
Section: Discussionsupporting
confidence: 83%
“… 23 IVIg is a blood product and its main component is protein, more than 95% of which is Ig, including IgG antibodies against a broad spectrum of viruses, bacteria and other pathogens. 24 Since plasma products can contain blood-group antibodies (e.g. anti-A, anti-B, anti-D), they can act as a haemolysin and induce red blood cell aggregation in the recipient, resulting in a positive direct antiglobulin test and haemolysis.…”
Section: Discussionmentioning
confidence: 99%